Home » Topics » BioWorld Science

BioWorld Science
RSS

LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria

June 16, 2021

FDA clears IND application for phase II study of LPCN-1154 in postpartum depression

June 16, 2021

XWPharma reports phase I data on XW-10172 for sleep disorders

June 15, 2021

EyeGate begins phase II proof-of-concept study of PP-001 for ocular surface inflammation

June 15, 2021

Mindset reports first preclinical psychedelic benchmark data from COPE program

June 15, 2021

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

G1 Therapeutics initiates phase II trial of Cosela in metastatic bladder cancer

June 15, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

Novadip reports phase I data on first-generation autologous cell-based osteogenic product NVD-001

June 15, 2021

Cocrystal's CDI-45205 shows in vitro activity against SARS-CoV-2 and variants

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...